The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market.

The global Autoimmune Disorder Drug Delivery Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Device.

Report Scope

The Autoimmune Disorder Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disorder Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autoimmune Disorder Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autoimmune Disorder Drug Delivery Device Market Report

Report Metric	Details
Report Name	Autoimmune Disorder Drug Delivery Device Market
CAGR	5%
Segment by Type	Pen Injectors Auto-Injectors Prefilled Syringes Vials
Segment by Application	In-house Manufacturing Outsourced Manufacturing
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autoimmune Disorder Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autoimmune Disorder Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The main players in the Autoimmune Disorder Drug Delivery Device Market are AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The Applications covered in the Autoimmune Disorder Drug Delivery Device Market report are In-house Manufacturing, Outsourced Manufacturing

What are the Type segmentation covered in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The Types covered in the Autoimmune Disorder Drug Delivery Device Market report are Pen Injectors, Auto-Injectors, Prefilled Syringes, Vials

1 Autoimmune Disorder Drug Delivery Device Market Overview

1.1 Product Overview and Scope of Autoimmune Disorder Drug Delivery Device

1.2 Autoimmune Disorder Drug Delivery Device Segment by Type

1.2.1 Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2024-2030)

1.2.2 Pen Injectors

1.2.3 Auto-Injectors

1.2.4 Prefilled Syringes

1.2.5 Vials

1.3 Autoimmune Disorder Drug Delivery Device Segment by Application

1.3.1 Global Autoimmune Disorder Drug Delivery Device Market Value by Application: (2024-2030)

1.3.2 In-house Manufacturing

1.3.3 Outsourced Manufacturing

1.4 Global Autoimmune Disorder Drug Delivery Device Market Size Estimates and Forecasts

1.4.1 Global Autoimmune Disorder Drug Delivery Device Revenue 2019-2030

1.4.2 Global Autoimmune Disorder Drug Delivery Device Sales 2019-2030

1.4.3 Global Autoimmune Disorder Drug Delivery Device Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Autoimmune Disorder Drug Delivery Device Market Competition by Manufacturers

2.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2019-2024)

2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Autoimmune Disorder Drug Delivery Device Average Price by Manufacturers (2019-2024)

2.4 Global Autoimmune Disorder Drug Delivery Device Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Product Type & Application

2.7 Autoimmune Disorder Drug Delivery Device Market Competitive Situation and Trends

2.7.1 Autoimmune Disorder Drug Delivery Device Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Autoimmune Disorder Drug Delivery Device Players Market Share by Revenue

2.7.3 Global Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Autoimmune Disorder Drug Delivery Device Retrospective Market Scenario by Region

3.1 Global Autoimmune Disorder Drug Delivery Device Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Autoimmune Disorder Drug Delivery Device Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2019-2030

3.2.1 Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2019-2024

3.2.2 Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2025-2030

3.3 Global Autoimmune Disorder Drug Delivery Device Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2019-2030

3.3.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2019-2024

3.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2025-2030

3.4 North America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country

3.4.1 North America Autoimmune Disorder Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2030)

3.4.3 North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country

3.5.1 Europe Autoimmune Disorder Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2030)

3.5.3 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country

3.6.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2030)

3.6.3 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country

3.7.1 Latin America Autoimmune Disorder Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2030)

3.7.3 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2030)

3.8.3 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2019-2030)

4.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2019-2024)

4.1.2 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2025-2030)

4.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2019-2030)

4.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2019-2030)

4.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2019-2024)

4.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2025-2030)

4.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2019-2030)

4.3 Global Autoimmune Disorder Drug Delivery Device Price by Type (2019-2030)

5 Segment by Application

5.1 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2019-2030)

5.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2019-2024)

5.1.2 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2025-2030)

5.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2019-2030)

5.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2019-2030)

5.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2019-2024)

5.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2025-2030)

5.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2019-2030)

5.3 Global Autoimmune Disorder Drug Delivery Device Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AbbVie Inc.

6.1.1 AbbVie Inc. Corporation Information

6.1.2 AbbVie Inc. Description and Business Overview

6.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.1.5 AbbVie Inc. Recent Developments/Updates

6.2 Amgen Inc.

6.2.1 Amgen Inc. Corporation Information

6.2.2 Amgen Inc. Description and Business Overview

6.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.2.5 Amgen Inc. Recent Developments/Updates

6.3 F. Hoffmann- La Roche Ltd.

6.3.1 F. Hoffmann- La Roche Ltd. Corporation Information

6.3.2 F. Hoffmann- La Roche Ltd. Description and Business Overview

6.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.3.4 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.3.5 F. Hoffmann- La Roche Ltd. Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Corporation Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis AG Autoimmune Disorder Drug Delivery Device Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 GlaxoSmithKline Plc

6.5.1 GlaxoSmithKline Plc Corporation Information

6.5.2 GlaxoSmithKline Plc Description and Business Overview

6.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Portfolio

6.5.5 GlaxoSmithKline Plc Recent Developments/Updates

6.6 Biogen Inc.

6.6.1 Biogen Inc. Corporation Information

6.6.2 Biogen Inc. Description and Business Overview

6.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.6.5 Biogen Inc. Recent Developments/Updates

6.7 Merck KGaA

6.6.1 Merck KGaA Corporation Information

6.6.2 Merck KGaA Description and Business Overview

6.6.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Portfolio

6.7.5 Merck KGaA Recent Developments/Updates

6.8 Bayer AG

6.8.1 Bayer AG Corporation Information

6.8.2 Bayer AG Description and Business Overview

6.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bayer AG Autoimmune Disorder Drug Delivery Device Product Portfolio

6.8.5 Bayer AG Recent Developments/Updates

6.9 Johnson & Johnson Services Inc.

6.9.1 Johnson & Johnson Services Inc. Corporation Information

6.9.2 Johnson & Johnson Services Inc. Description and Business Overview

6.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.9.5 Johnson & Johnson Services Inc. Recent Developments/Updates

6.10 Teva Pharmaceutical Industries Ltd.

6.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information

6.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.11 Eli Lily and Company

6.11.1 Eli Lily and Company Corporation Information

6.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Description and Business Overview

6.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Portfolio

6.11.5 Eli Lily and Company Recent Developments/Updates

6.12 Sanofi S.A.

6.12.1 Sanofi S.A. Corporation Information

6.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Description and Business Overview

6.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Portfolio

6.12.5 Sanofi S.A. Recent Developments/Updates

6.13 Takeda Pharmaceutical Company Limited

6.13.1 Takeda Pharmaceutical Company Limited Corporation Information

6.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Description and Business Overview

6.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Portfolio

6.13.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Autoimmune Disorder Drug Delivery Device Industry Chain Analysis

7.2 Autoimmune Disorder Drug Delivery Device Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Autoimmune Disorder Drug Delivery Device Production Mode & Process

7.4 Autoimmune Disorder Drug Delivery Device Sales and Marketing

7.4.1 Autoimmune Disorder Drug Delivery Device Sales Channels

7.4.2 Autoimmune Disorder Drug Delivery Device Distributors

7.5 Autoimmune Disorder Drug Delivery Device Customers

8 Autoimmune Disorder Drug Delivery Device Market Dynamics

8.1 Autoimmune Disorder Drug Delivery Device Industry Trends

8.2 Autoimmune Disorder Drug Delivery Device Market Drivers

8.3 Autoimmune Disorder Drug Delivery Device Market Challenges

8.4 Autoimmune Disorder Drug Delivery Device Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AbbVie

Amgen Inc

F Hoffmann La Roche Ltd

Johnson & Johnson Services Inc.

Teva Pharmaceutical Industries Ltd

Eli Lily And Company

Sanofi

Takeda Pharmaceutical Company Limited

List of Tables

Table 1. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Autoimmune Disorder Drug Delivery Device Market Competitive Situation by Manufacturers in 2023

Table 4. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Autoimmune Disorder Drug Delivery Device Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Autoimmune Disorder Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Autoimmune Disorder Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Product Type & Application

Table 12. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Autoimmune Disorder Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Device as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Autoimmune Disorder Drug Delivery Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Autoimmune Disorder Drug Delivery Device Sales by Region (2019-2024) & (K Units)

Table 18. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2019-2024)

Table 19. Global Autoimmune Disorder Drug Delivery Device Sales by Region (2025-2030) & (K Units)

Table 20. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2025-2030)

Table 21. Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2019-2024)

Table 23. Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2025-2030)

Table 25. North America Autoimmune Disorder Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2024) & (K Units)

Table 27. North America Autoimmune Disorder Drug Delivery Device Sales by Country (2025-2030) & (K Units)

Table 28. North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2024) & (K Units)

Table 32. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2025-2030) & (K Units)

Table 33. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Type (2019-2024)

Table 51. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Type (2025-2030)

Table 52. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2019-2024)

Table 53. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2025-2030)

Table 54. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2019-2024)

Table 57. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2025-2030)

Table 58. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2019-2024)

Table 59. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2025-2030)

Table 60. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Application (2019-2024)

Table 61. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Application (2025-2030)

Table 62. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2019-2024)

Table 63. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2025-2030)

Table 64. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2019-2024)

Table 67. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2025-2030)

Table 68. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2019-2024)

Table 69. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2025-2030)

Table 70. AbbVie Inc. Corporation Information

Table 71. AbbVie Inc. Description and Business Overview

Table 72. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product

Table 74. AbbVie Inc. Recent Developments/Updates

Table 75. Amgen Inc. Corporation Information

Table 76. Amgen Inc. Description and Business Overview

Table 77. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product

Table 79. Amgen Inc. Recent Developments/Updates

Table 80. F. Hoffmann- La Roche Ltd. Corporation Information

Table 81. F. Hoffmann- La Roche Ltd. Description and Business Overview

Table 82. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product

Table 84. F. Hoffmann- La Roche Ltd. Recent Developments/Updates

Table 85. Novartis AG Corporation Information

Table 86. Novartis AG Description and Business Overview

Table 87. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis AG Autoimmune Disorder Drug Delivery Device Product

Table 89. Novartis AG Recent Developments/Updates

Table 90. GlaxoSmithKline Plc Corporation Information

Table 91. GlaxoSmithKline Plc Description and Business Overview

Table 92. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product

Table 94. GlaxoSmithKline Plc Recent Developments/Updates

Table 95. Biogen Inc. Corporation Information

Table 96. Biogen Inc. Description and Business Overview

Table 97. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product

Table 99. Biogen Inc. Recent Developments/Updates

Table 100. Merck KGaA Corporation Information

Table 101. Merck KGaA Description and Business Overview

Table 102. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Merck KGaA Autoimmune Disorder Drug Delivery Device Product

Table 104. Merck KGaA Recent Developments/Updates

Table 105. Bayer AG Corporation Information

Table 106. Bayer AG Description and Business Overview

Table 107. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Bayer AG Autoimmune Disorder Drug Delivery Device Product

Table 109. Bayer AG Recent Developments/Updates

Table 110. Johnson & Johnson Services Inc. Corporation Information

Table 111. Johnson & Johnson Services Inc. Description and Business Overview

Table 112. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product

Table 114. Johnson & Johnson Services Inc. Recent Developments/Updates

Table 115. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 116. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 117. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product

Table 119. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 120. Eli Lily and Company Corporation Information

Table 121. Eli Lily and Company Description and Business Overview

Table 122. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product

Table 124. Eli Lily and Company Recent Developments/Updates

Table 125. Sanofi S.A. Corporation Information

Table 126. Sanofi S.A. Description and Business Overview

Table 127. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product

Table 129. Sanofi S.A. Recent Developments/Updates

Table 130. Takeda Pharmaceutical Company Limited Corporation Information

Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview

Table 132. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product

Table 134. Takeda Pharmaceutical Company Limited Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Autoimmune Disorder Drug Delivery Device Distributors List

Table 138. Autoimmune Disorder Drug Delivery Device Customers List

Table 139. Autoimmune Disorder Drug Delivery Device Market Trends

Table 140. Autoimmune Disorder Drug Delivery Device Market Drivers

Table 141. Autoimmune Disorder Drug Delivery Device Market Challenges

Table 142. Autoimmune Disorder Drug Delivery Device Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Autoimmune Disorder Drug Delivery Device

Figure 2. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Autoimmune Disorder Drug Delivery Device Market Share by Type in 2023 & 2030

Figure 4. Pen Injectors Product Picture

Figure 5. Auto-Injectors Product Picture

Figure 6. Prefilled Syringes Product Picture

Figure 7. Vials Product Picture

Figure 8. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Autoimmune Disorder Drug Delivery Device Market Share by Application in 2023 & 2030

Figure 10. In-house Manufacturing

Figure 11. Outsourced Manufacturing

Figure 12. Global Autoimmune Disorder Drug Delivery Device Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Autoimmune Disorder Drug Delivery Device Market Size (2019-2030) & (US$ Million)

Figure 14. Global Autoimmune Disorder Drug Delivery Device Sales (2019-2030) & (K Units)

Figure 15. Global Autoimmune Disorder Drug Delivery Device Average Price (US$/Unit) & (2019-2030)

Figure 16. Autoimmune Disorder Drug Delivery Device Report Years Considered

Figure 17. Autoimmune Disorder Drug Delivery Device Sales Share by Manufacturers in 2023

Figure 18. Global Autoimmune Disorder Drug Delivery Device Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Device Players: Market Share by Revenue in 2023

Figure 20. Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Autoimmune Disorder Drug Delivery Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2019-2030)

Figure 23. North America Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2019-2030)

Figure 24. United States Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2019-2030)

Figure 27. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2019-2030)

Figure 28. Germany Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2019-2030)

Figure 35. China Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2019-2030)

Figure 45. Latin America Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Colombia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Autoimmune Disorder Drug Delivery Device by Type (2019-2030)

Figure 56. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Device by Type (2019-2030)

Figure 57. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Autoimmune Disorder Drug Delivery Device by Application (2019-2030)

Figure 59. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Device by Application (2019-2030)

Figure 60. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2019-2030)

Figure 61. Autoimmune Disorder Drug Delivery Device Value Chain

Figure 62. Autoimmune Disorder Drug Delivery Device Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions